MAXSMAKING INC- CL A (MAMK) Fundamental Analysis & Valuation
NASDAQ:MAMK • VGG6053R1064
Current stock price
13 USD
-0.02 (-0.15%)
At close:
13 USD
0 (0%)
After Hours:
This MAMK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MAMK Profitability Analysis
1.1 Basic Checks
- In the past year MAMK was profitable.
- MAMK had a negative operating cash flow in the past year.
1.2 Ratios
- With an excellent Return On Assets value of 12.41%, MAMK belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
- MAMK's Return On Equity of 30.23% is amongst the best of the industry. MAMK outperforms 83.33% of its industry peers.
- MAMK has a better Return On Invested Capital (19.45%) than 85.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.41% | ||
| ROE | 30.23% | ||
| ROIC | 19.45% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 7.27%, MAMK belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
- MAMK has a Operating Margin of 9.17%. This is in the better half of the industry: MAMK outperforms 75.00% of its industry peers.
- The Gross Margin of MAMK (16.04%) is worse than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.17% | ||
| PM (TTM) | 7.27% | ||
| GM | 16.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. MAMK Health Analysis
2.1 Basic Checks
- MAMK has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
2.2 Solvency
- MAMK has an Altman-Z score of 17.49. This indicates that MAMK is financially healthy and has little risk of bankruptcy at the moment.
- MAMK has a Altman-Z score of 17.49. This is amongst the best in the industry. MAMK outperforms 100.00% of its industry peers.
- MAMK has a Debt/Equity ratio of 0.64. This is a neutral value indicating MAMK is somewhat dependend on debt financing.
- MAMK's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. MAMK is outperformed by 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 17.49 |
ROIC/WACC2.17
WACC8.96%
2.3 Liquidity
- MAMK has a Current Ratio of 1.71. This is a normal value and indicates that MAMK is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.71, MAMK perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
- MAMK has a Quick Ratio of 1.43. This is a normal value and indicates that MAMK is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.43, MAMK is in the better half of the industry, outperforming 79.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.43 |
3. MAMK Growth Analysis
3.1 Past
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-36.7%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. MAMK Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 118.18, the valuation of MAMK can be described as expensive.
- Based on the Price/Earnings ratio, MAMK is valued a bit more expensive than 75.00% of the companies in the same industry.
- When comparing the Price/Earnings ratio of MAMK to the average of the S&P500 Index (25.60), we can say MAMK is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 118.18 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, MAMK is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 88.71 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. MAMK Dividend Analysis
5.1 Amount
- No dividends for MAMK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MAMK Fundamentals: All Metrics, Ratios and Statistics
13
-0.02 (-0.15%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change6263.82%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap216.06M
Revenue(TTM)26.26M
Net Income(TTM)1.91M
AnalystsN/A
Price TargetN/A
Short Float %2.92%
Short Ratio0.12
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 118.18 | ||
| Fwd PE | N/A | ||
| P/S | 8.23 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 34.21 | ||
| P/tB | 34.26 | ||
| EV/EBITDA | 88.71 |
EPS(TTM)0.11
EY0.85%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.58
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.41% | ||
| ROE | 30.23% | ||
| ROCE | 34.04% | ||
| ROIC | 19.45% | ||
| ROICexc | 19.86% | ||
| ROICexgc | 19.88% | ||
| OM | 9.17% | ||
| PM (TTM) | 7.27% | ||
| GM | 16.04% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.67 | ||
| Cap/Depr | 56.94% | ||
| Cap/Sales | 0.06% | ||
| Interest Coverage | 24.94 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.43 | ||
| Altman-Z | 17.49 |
F-ScoreN/A
WACC8.96%
ROIC/WACC2.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-36.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
MAXSMAKING INC- CL A / MAMK Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MAXSMAKING INC- CL A?
ChartMill assigns a fundamental rating of 2 / 10 to MAMK.
What is the valuation status of MAXSMAKING INC- CL A (MAMK) stock?
ChartMill assigns a valuation rating of 0 / 10 to MAXSMAKING INC- CL A (MAMK). This can be considered as Overvalued.
How profitable is MAXSMAKING INC- CL A (MAMK) stock?
MAXSMAKING INC- CL A (MAMK) has a profitability rating of 4 / 10.
How financially healthy is MAXSMAKING INC- CL A?
The financial health rating of MAXSMAKING INC- CL A (MAMK) is 4 / 10.